Aristides Capital’s Protolabs PRLB Stock Holding History

Aristides Capital’s Portfolio PRLB Stock Details PRLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9,035	Closed	-$231K	–	231
2022 Q4	$231K	Buy	+9,035	New	+$268K	0.12%	146

Other funds holding PRLB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Aristides Capital's PRLB Position: Q1 2023 in Review

Aristides Capital sold out of Protolabs (PRLB) in Q1 2023, closing a stake of 9,035 shares — an estimated $231K sold.

Aristides Capital first reported a position in PRLB in Q4 2022 and held it in 1 quarter. The position peaked at $231K in Q4 2022. 198 funds tracked by Wall St. Rank hold PRLB as of Q1 2023.

Aristides Capital reported no remaining Protolabs position as of Q1 2023 after selling out during the quarter.
Aristides Capital sold 9,035 Protolabs shares in Q1 2023, an estimated $231K.
Aristides Capital first reported a position in Protolabs in Q4 2022 and held it in 1 quarter.
Aristides Capital's Protolabs position peaked at $231K in Q4 2022.
198 funds tracked by Wall St. Rank held Protolabs as of Q1 2023.

Based on Aristides Capital's 13F filing for Q1 2023, filed 12 May 2023.